Prevention & Chronic Conditions

Broadcast

Assessing the Shift Towards Personalised Medicine – Part 1

Jordana B Cohen, Kazem Rahimi

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Finerenone: Will It Be a Game-changer?

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

Aldosterone and Potassium in Heart Failure

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

CPET and Exercise Prescription for Cardiac Rehabilitation

Published:

20 December 2024

Citation:

US Cardiology Review 2024;18:e22.

Risk Prediction of CVD in the Asia-Pacific Region

Published:

29 November 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e43.